Provided by Jorge Goldstein
Jorge A. Goldstein, Ph.D., is a founder of the firm and a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. He has four decades of experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, pharmaceuticals, and more recently BioFETs.
He established the firm's IP and Human Rights Pro Bono Practice, which integrates IP law with economic, social, and cultural rights to empower disenfranchised communities.
Jorge has handled multiple and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He has been involved in inter partes reviews at the USPTO, as well as European oppositions, and arbitrations in District Court and in Appellate litigation both as counsel and expert witness, and in counseling clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements.